Dcr3 inhibit p53-dependent apoptosis in gamma-irradiated lung cancer cells

Hye Youn Sung1, Hong-Gyun Wu, Jung-Hyuck Ahn

  • 1Department of Biomedical Sciences, Biochemistry and Molecular Biology, Seoul National University College of Medicine, Seoul, Korea.

Abstract

Insights

Decoy receptor 3 (Dcr3) expression is higher in radioresistant lung cancer cells and influences cell survival. Dcr3, along with p53-dependent apoptosis, regulates cellular response to ionizing radiation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Lung cancer cell line radiosensitivity varies significantly.
  • Understanding the genetic basis of radioresistance is crucial for effective cancer therapy.

Purpose of the Study:

  • To identify genes associated with radiosensitivity in lung cancer.
  • To compare gene expression profiles between radioresistant (H1299) and radiosensitive (H460) lung cancer cell lines.

Main Methods:

  • Microarray analysis to assess mRNA profiles.
  • Quantitative real-time PCR (qRT-PCR) and Western blot for gene expression validation.
  • Clonogenic assay to measure cellular radioresistance.

Main Results:

  • Decoy receptor 3 (Dcr3) expression was significantly higher in radioresistant cell lines compared to radiosensitive ones.
  • Overexpression of Dcr3 enhanced survival in radiosensitive cells, while Dcr3 knockdown reduced radioresistance.
  • Dcr3's role in radioresistance is p53-dependent, involving the Fas-mediated apoptosis pathway.

Conclusions:

  • Dcr3 expression is a key regulator of cellular response to ionizing radiation in lung cancer.
  • The p53-dependent apoptosis signaling pathway, influenced by Dcr3, plays a critical role in radiosensitivity.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.